Searched for
MSME DRUG COMPANIES
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Vijay sworn in as Tamil Nadu CM: Here's what TVK promised ahead of Assembly pollsTamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Meet the winners of the ET MSME Awards 2025From nanobubble tech and agro-exports to e-waste recycling and specialty chemicals, the best Indian MSMEs across 20 categories redefined wh...
- Small pharma firms may face closure as regulator tightens quality checksMany small drug makers face closure as regulators inspect facilities for quality standards. Thousands of plants may shut down if upgrades a...
- ET MSME Awards 2025: India's pharma MSMEs face existential choiceNew bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...
- Drug companies flag concerns over timeline for carrying out regulator's manufacturing ruleSmall and medium pharmaceutical companies are appealing to the health minister, raising concerns about stringent manufacturing standards im...
- Pharma lobby flags 'cumbersome' export rule, seeks changePharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export...
- Many MSME pharma firms making substandard drugs, CDSCO data showsData from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to meet safety st...
- Several small pharma units told to halt operations over qualityThe Central Drugs Standard Control Organisation (CDSCO) has been conducting risk-based inspections of drug manufacturing units as part of a...
- Halt inspections, help MSMEs, drug cos' body tells Health minister Mansukh Mandaviya"We had met the minister and urged him to help the MSME sector. We want the officials at the regulatory body to become facilitators for the...
- Government orders new drug-making standards after overseas deathsThe Indian government has issued a notification requiring pharmaceutical companies to adhere to new manufacturing standards in response to ...
- 'Over 15% of medicines made by small companies are of poor quality'The Central Drugs Standard Control Organisation (CDSCO), along with state drug inspectors, has been carrying out inspections as part of a n...
- MSME Pharma companies under the lens over drug quality issuesMore than 65% of MSME firms have been found to be manufacturing drugs that are not of standard quality (NSQ), during risk-based inspections...
- Mandaviya asks MSME pharma firms to move towards good manufacturing practices through self regulationUnion minister, Mansukh Mandaviya, has told representatives of the pharmaceutical industry that Schedule M, which requires adherence to goo...
Load More
